#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heart disease congenital Malignant central nervous system neoplasm Metachromatic leukodystrophy Choroid melanoma Biliary neoplasm Vulval cancer recurrent Osteopetrosis Li-Fraumeni syndrome Scedosporium infection Non-small cell lung cancer Duchenne muscular dystrophy Biotinidase deficiency Eosinophilic granulomatosis with polyangiitis Hepatic angiosarcoma Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma Hypereosinophilic syndrome Stevens-Johnson syndrome – Trials in Disease Advanced systemic mastocytosis Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Uterine leiomyosarcoma – Life with Disease Loeys-Dietz syndrome Congenital generalised lipodystrophy – Basic Information Ewing’s sarcoma recurrent – Trials in Disease Rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clofutriben Fluticasone Phleum Pratense Pollen Extract BNT327 Oxogluric Acid Levomepromazine Hydrochloride Gallium (68Ga) Gozetotide AZD3632 Permethrin Crizanlizumab SP16 SODIUM SULFIDE NONAHYDRATE Desogestrel Formoterol Fumarate Dihydrate Piperacillin Tarlatamab Selexipag Prilocaine Nitric Oxide L-Acetylleucine More therapies…

    Learn about Your Condition

    Head and neck cancer stage IV Immune thrombocytopenia Erythema migrans Mesothelioma malignant Glioma Corneal graft failure Neuralgia Pemphigoid Acute leukaemia Becker's muscular dystrophy Delayed graft function Mantle cell lymphoma stage III Arginase deficiency Infective uveitis Obesity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin
    Sweden

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    Investigated Drugs:
    • Benzylpenicillin
    • Clindamycin
    • Cloxacillin
    Denmark

  • Study on Ceftriaxone Dosing for Patients with Severe Community-Acquired Pneumonia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Ceftriaxone
    Belgium

  • Study on Customized Antibiotic Treatment Duration for Hospitalized Patients with Community-Acquired Pneumonia Using Cefotaxime and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Levofloxacin
    • Pristinamycin
    • Sodium
    France

  • Study Comparing Amoxicillin and Amoxicillin/Clavulanic Acid for Treating Community-Acquired Pneumonia in Patients Aged 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France

  • Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • Aztreonam
    • Contezolid
    • Linezolid
    Bulgaria Croatia Czechia Estonia France Greece +9
Previous Page
1 … 16 17 18 19 20 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!